Statements (381)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:pharmaceuticals
gptkb:Company |
| gptkbp:accessories |
nucleotide solutions
reagents for chromatography |
| gptkbp:acquired |
gptkb:Millipore
gptkb:Millipore_Corporation |
| gptkbp:acquisition |
gptkb:Millipore
gptkb:Millipore_Sigma gptkb:Acceleron_Pharma gptkb:Onco_Immune gptkb:Schering-Plough gptkb:Afferent_Pharmaceuticals Antelliq |
| gptkbp:advertising |
gptkb:Dr._David_W._Johnson
|
| gptkbp:aims_to |
improve healthcare
|
| gptkbp:animal_health_division |
gptkb:Merck_Animal_Health
|
| gptkbp:awards |
gptkb:Fortune_500
Best Places to Work various industry awards World's Most Admired Companies |
| gptkbp:benefits |
comprehensive health benefits
|
| gptkbp:ceo |
gptkb:Robert_M._Davis
|
| gptkbp:clinical_trial |
ongoing
collaborates with hospitals collaborates with universities conducts thousands annually invests in biotechnology Phase III trials ongoing develops gene therapies ongoing for various drugs focuses on rare diseases |
| gptkbp:collaborates_with |
academic institutions
research institutions research organizations |
| gptkbp:collaboration |
academic institutions
GSK for COVID-19 vaccine |
| gptkbp:collaborations |
with research institutions
|
| gptkbp:community_engagement |
healthcare access programs
|
| gptkbp:community_health |
focus on access to medicines
|
| gptkbp:community_outreach |
health education initiatives
|
| gptkbp:competes_with |
other pharmaceutical companies
|
| gptkbp:competitors |
gptkb:Johnson_&_Johnson
gptkb:Astra_Zeneca gptkb:Pfizer gptkb:Roche gptkb:Novartis |
| gptkbp:conducts_research_on |
gptkb:Roger_Perlmutter
gptkb:Dr._Roger_Perlmutter gptkb:Dr._Julie_Gerberding |
| gptkbp:contributes_to |
gptkb:scientific_research
|
| gptkbp:covid-19_impact |
developed antiviral treatments
|
| gptkbp:development |
thousands of employees
|
| gptkbp:develops |
diagnostic tools
analytical methods enzymes for molecular biology |
| gptkbp:distributes |
PCR kits
|
| gptkbp:divisions |
gptkb:Merck_KGa_A
life science products |
| gptkbp:employees |
over 70,000
approximately 74,000 Over 70,000 approximately 74,000 (2020) |
| gptkbp:employs |
gptkb:engineers
gptkb:scientists over 70,000 people sales professionals |
| gptkbp:engages_in |
gptkb:biotechnology
research and development clinical research |
| gptkbp:focus |
Pharmaceuticals
|
| gptkbp:focuses_on |
gptkb:biotechnology
research and development |
| gptkbp:founded |
1891
|
| gptkbp:founded_in |
1668
1891 |
| gptkbp:founder |
gptkb:George_W._Merck
|
| gptkbp:funding |
over $10 billion annually
|
| gptkbp:global_presence |
gptkb:pharmaceuticals
over 140 countries operates in over 140 countries in over 70 countries |
| gptkbp:has |
global presence
partnerships with universities a diverse product portfolio a strong R& D division |
| gptkbp:has_a_diverse_product_line_that_includes |
diagnostic reagents
|
| gptkbp:has_a_focus_on |
gptkb:diabetes
gptkb:collaboration gptkb:supply_chain_management gptkb:sustainable_development_goals research and development patient education patient safety regulatory compliance chronic disease management neurology oncology patient-centered care rare diseases environmental sustainability antibiotic resistance vaccines emerging markets health equity safety and efficacy cardiovascular diseases infectious diseases immunology pharmacovigilance research integrity environmental health precision medicine digital health solutions healthcare innovation patient-centric solutions biopharmaceutical development research partnerships. patient access clinical research ethics therapeutic areas such as oncology |
| gptkbp:has_a_presence_in |
over 70 countries
the global market |
| gptkbp:has_a_reputation_for |
high-quality products
|
| gptkbp:has_a_research_and_development_budget_of |
billions of dollars
|
| gptkbp:has_a_strong_pipeline_of |
new therapies
|
| gptkbp:has_awards |
corporate responsibility
innovation awards |
| gptkbp:has_culture |
inclusive work environment
|
| gptkbp:has_diversity_initiatives |
workforce diversity
supplier diversity workplace diversity programs |
| gptkbp:has_history |
gptkb:Philanthropy
collaborative research projects scientific breakthroughs pharmaceutical breakthroughs |
| gptkbp:has_mission |
improve health outcomes
improve human health |
| gptkbp:has_part |
manufacturing plants
R& D facilities flow cytometry division |
| gptkbp:has_partnerships_with |
academic institutions
biotech companies various research institutions |
| gptkbp:has_product |
gptkb:National_Institutes_of_Health
data analysis tools data visualization tools biostatistics software molecular modeling software biological data integration tools clinical trial data analysis software drug discovery informatics tools genomic data management solutions predictive analytics platforms |
| gptkbp:has_product_line |
flow cytometry
|
| gptkbp:has_received |
numerous awards
numerous awards for research |
| gptkbp:has_research_center |
gptkb:Beijing,_China
gptkb:Boston gptkb:Darmstadt,_Germany gptkb:Singapore gptkb:West_Point,_Pennsylvania gptkb:Rahway,_New_Jersey |
| gptkbp:has_research_focus |
cancer therapies
|
| gptkbp:headquartered_in |
gptkb:Kenilworth,_New_Jersey
|
| gptkbp:headquarters |
gptkb:Kenilworth,_New_Jersey,_USA
gptkb:Kenilworth,_New_Jersey |
| https://www.w3.org/2000/01/rdf-schema#label |
Merck
|
| gptkbp:industry |
gptkb:pharmaceuticals
|
| gptkbp:innovation |
focus on patient-centered solutions
|
| gptkbp:invention |
numerous pharmaceutical patents
thousands of pharmaceutical patents |
| gptkbp:investment |
genetic research
biotechnology research in renewable energy projects in digital health technologies |
| gptkbp:investment_strategy |
traded on NYSE
|
| gptkbp:is |
publicly traded
a leader in biotechnology |
| gptkbp:is_a_member_of |
gptkb:S&_P_500
various industry associations |
| gptkbp:is_active_in |
global markets
|
| gptkbp:is_committed_to |
scientific excellence
diversity and inclusion patient education patient safety sustainability research funding sustainability initiatives ethical practices open science innovation in healthcare corporate responsibility affordable healthcare solutions |
| gptkbp:is_displayed_in |
gptkb:New_York_Stock_Exchange
gptkb:Fortune_500 |
| gptkbp:is_engaged_in |
digital transformation
global health initiatives |
| gptkbp:is_focused_on |
innovation
|
| gptkbp:is_incorporated_in |
gptkb:New_Jersey
|
| gptkbp:is_involved_in |
gptkb:biotechnology
environmental initiatives regulatory compliance clinical trials community outreach programs community engagement initiatives public health campaigns global health initiatives vaccine development collaborative research projects healthcare access initiatives patient advocacy programs healthcare technology advancements healthcare policy advocacy regulatory affairs biopharmaceutical manufacturing healthcare innovation. diagnostic solutions pharmaceutical research and development |
| gptkbp:is_known_for |
high-quality products
innovative solutions animal health products collaborative research vaccines cancer therapies pharmaceutical innovations biotechnology innovations its transparency in operations its commitment to innovation its ethical standards its extensive patent portfolio its global health partnerships its innovative drug delivery systems its research collaborations. its vaccine development |
| gptkbp:is_recognized_for |
scientific excellence
quality assurance scientific contributions its contributions to science its scientific publications its contributions to public health its ethical standards its leadership in the industry quality control solutions |
| gptkbp:leadership |
life sciences
pharmaceutical manufacturing pharmaceutical innovation diverse leadership team committed to diversity and inclusion. |
| gptkbp:market |
global pharmaceutical market
|
| gptkbp:market_cap |
approximately $200 billion (2022)
|
| gptkbp:marketing_strategy |
focus on innovation
|
| gptkbp:number_of_employees |
approximately 74,000
|
| gptkbp:offers |
DNA polymerases
liquid chromatography systems customized services biotechnology products training programs for researchers proteomics products genetic engineering solutions genomic solutions cell analysis tools customized flow cytometry solutions customized reagents gas chromatography systems software for chromatography data analysis |
| gptkbp:operates_in |
gptkb:pharmaceuticals
life sciences more than 70 countries |
| gptkbp:partnership |
gptkb:Eli_Lilly
gptkb:GSK gptkb:Astra_Zeneca gptkb:Sanofi gptkb:Bristol-Myers_Squibb gptkb:Pfizer gptkb:IAVI gptkb:Bayer gptkb:Amgen gptkb:Eisai GSK for vaccines Pfizer for COVID-19 treatment Pfizer for vaccine development with WHO for global health initiatives Abb Vie for oncology research Amgen for immunology research Astra Zeneca for drug development Boehringer Ingelheim for respiratory research Bristol-Myers Squibb for cancer research Celgene for hematology research Eli Lilly for diabetes research Gilead for antiviral research IAVI for HIV vaccine research Illumina for genomic research Moderna for m RNA technology Nant Kwest for immunotherapy Novartis for gene therapy Regeneron for antibody development Roche for diagnostics Sanofi for vaccine development Siemens Healthineers for diagnostic imaging. Takeda for gastrointestinal research Thermo Fisher Scientific for lab services Vertex Pharmaceuticals for cystic fibrosis research with NGOs for health initiatives |
| gptkbp:philanthropy |
gptkb:Merck_Foundation
|
| gptkbp:portfolio_company |
biologics
analytical instruments cell sorting technologies |
| gptkbp:produces |
gptkb:CRISPR_products
reagents flow cytometry products chromatography products gene editing products cell sorting products reagents for PCR |
| gptkbp:products |
antibiotics
vaccines biologics prescription medications cancer therapies diabetes medications |
| gptkbp:provides |
quality control standards
healthcare solutions cell culture products scientific support laboratory supplies chromatography columns PCR buffers chromatography consumables training for chromatography techniques |
| gptkbp:provides_guidance_on |
contributes to clinical guidelines
|
| gptkbp:publications |
publishes research findings
|
| gptkbp:range |
laboratory instruments
|
| gptkbp:regulatory_compliance |
FDA approvals for drugs
|
| gptkbp:research |
vaccine development
cancer treatments cardiovascular drugs HIV treatments vaccines for HPV diabetes treatments |
| gptkbp:research_areas |
cardiology
neurology oncology infectious diseases immunology |
| gptkbp:research_focus |
gptkb:diabetes
vaccines immuno-oncology cardiovascular diseases |
| gptkbp:revenue |
$48.7 billion (2020)
$48 billion (2020) $48 billion (2022) $59.3 billion (2022) |
| gptkbp:serves |
laboratories
healthcare industry |
| gptkbp:social_responsibility |
commitment to ethical practices
|
| gptkbp:stock_exchange |
gptkb:New_York_Stock_Exchange
gptkb:NYSE gptkb:the_New_York_Stock_Exchange |
| gptkbp:stock_symbol |
MRK
|
| gptkbp:subsidiaries |
gptkb:Merck_Sharp_&_Dohme
|
| gptkbp:subsidiary |
gptkb:Millipore_Sigma
gptkb:Merck_Sharp_&_Dohme |
| gptkbp:supply_chain |
global supply chain management
sustainable sourcing practices |
| gptkbp:supports |
gptkb:scientific_research
scientific education educational initiatives in science |
| gptkbp:sustainability_initiatives |
community engagement
environmental responsibility access to medicines environmental responsibility programs |
| gptkbp:traded_on |
gptkb:NYSE
|
| gptkbp:training |
ongoing professional development programs
|
| gptkbp:type |
gptkb:public_company
|
| gptkbp:uses_technology |
invests in biotech innovations
|
| gptkbp:was_a_pioneer_in |
biopharmaceuticals
pharmaceutical technology |
| gptkbp:website |
merck.com
|
| gptkbp:bfsParent |
gptkb:Snowflake
gptkb:Blueprint_Medicines |
| gptkbp:bfsLayer |
4
|